Ticker Details
Haemonetics Corporation Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$4.95B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 1.25%
Avg Daily Range (30 D):	$1.79 | 2.04%
Avg Daily Range (90 D):	$1.50 | 2.07%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.68M

Trade Size
Avg Trade Size (Sh.):	78
Avg Trade Size (Sh.) (30 D):	46
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	9,594
Avg Institutional Trade:	$2.84M
Avg Institutional Trade (30 D):	$4.35M
Avg Institutional Trade (90 D):	$4.35M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.13M
Avg Closing Trade (30 D):	$9.34M
Avg Closing Trade (90 D):	$9.92M
Avg Closing Volume:	58.52K

News

Jul 24, 2026 @ 2:46 PM Global Apheresis Market to Reach USD 4.41 Billion ... Source: Researchandmarkets.Com

Jun 25, 2026 @ 2:30 AM [Latest] Global Therapeutic Apheresis Market Size/... Source: Healthcare Foresights

Jan 9, 2026 @ 1:16 PM Haemonetics Expands Heart Surgery Arsenal With Viv... Source: Akanksha Bakshi

Aug 14, 2025 @ 2:58 PM Patient Blood Management Market Growth Analysis Re... Source: Researchandmarkets.Com

Aug 7, 2025 @ 10:33 AM Haemonetics (HAE) Q1 Revenue Falls 4% Source: Jesterai

Financials
	TTM	Q1 2027	Q4 2026
Basic EPS	$2.09	$.73	$-.41
Diluted EPS	$2.07	$.72	$-.41
Revenue	$1.35B	$339.38M	$346.35M
Gross Profit	$798.15M	$202.8M	$198.21M
Net Income / Loss	$96.29M	$33.01M	$-20.15M
Operating Income / Loss	$160.32M	$57.46M	$-23.03M
Cost of Revenue	$553.87M	$136.58M	$148.14M
Net Cash Flow	$-69.51M	$-22.06M	$-117.93M
PE Ratio

Splits
Dec 03, 2012	2:1